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Oscillatory cAMP signaling rapidly alters H3K4
methylation
Tyler C Huff1,*, Vladimir Camarena1,* , David W Sant1, Zachary Wilkes1, Derek Van Booven1, Allegra T Aron2, Ryan K Muir3,
Adam R Renslo3 , Christopher J Chang2,4,5, Paula V Monje6, Gaofeng Wang1,7
Epigenetic variation reﬂects the impact of a dynamic environment
on chromatin. However, it remains elusive how environmental
factors inﬂuence epigenetic events. Here, we show that G
protein–coupled receptors (GPCRs) alter H3K4 methylation via
oscillatory intracellular cAMP. Activation of Gs-coupled receptors
caused a rapid decrease of H3K4me3 by elevating cAMP, whereas
stimulation of Gi-coupled receptors increased H3K4me3 by di-
minishing cAMP. H3K4me3 gradually recovered towards baseline
levels after the removal of GPCR ligands, indicating that H3K4me3
oscillates in tandem with GPCR activation. cAMP increased intra-
cellular labile Fe(II), the cofactor for histone demethylases, through
a non-canonical cAMP target—Rap guanine nucleotide exchange
factor-2 (RapGEF2), which subsequently enhanced endosome
acidiﬁcation and Fe(II) release from the endosome via vacuolar H+-
ATPase assembly. Removing Fe(III) from the media blocked in-
tracellular Fe(II) elevation after stimulation of Gs-coupled recep-
tors. Iron chelators and inhibition of KDM5 demethylases abolished
cAMP-mediated H3K4me3 demethylation. Taken together, these
results suggest a novel function of cAMP signaling in modulating
histone demethylation through labile Fe(II).
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Introduction
Cellular systems constantly respond to a barrage of environmental
stimuli by transducing extracellular signals into transcriptional
changes. G protein–coupled receptors (GPCRs) are the largest and
most diverse group of membrane receptors which sense extra-
cellular changes by binding with speciﬁc ligands (Lefkowitz, 2007).
The binding of agonists to Gs-coupled receptors elevates, whereas
binding to Gi-coupled receptors suppresses, the secondmessenger
cAMP to induce downstream molecular changes in response to
environmental stimuli (Sutherland, 1970; Sunahara et al, 1996).
Under physiological conditions, stimuli for GPCRs are often per-
sistent and periodic which could result in a long-term oscillation of
intracellular cAMP (Dyachok et al, 2006). Furthermore, activators or
inhibitors of adenylate cyclases (ACs), which produce cAMP, and of
phosphodiesterase (PDE), which degrade cAMP, can directly change
the level of intracellular cAMP. For example, bicarbonate and
caffeine both increase intracellular cAMP by activating soluble AC
and inhibiting PDE, respectively. The signal transduction of GPCRs
via cAMP has been extensively studied for decades and is thought
to be well established. The impact of cAMP on gene transcription is
considered to be mediated by three transcription factors (CREB,
ATF1, and CRE) which can be phosphorylated by cAMP-dependent
PKA (Montminy, 1997). The phosphorylation of these transcription
factors generally activates gene expression and is thought to be the
primary link between cAMP signaling and transcription (Sands &
Palmer, 2008).
We recently reported that cAMP also inﬂuences transcription by
promoting DNA hydroxymethylation, the initial step of active DNA
demethylation (Camarena et al, 2017). This effect was found to be
mediated by a cAMP-induced elevation of intracellular labile Fe(II),
an essential cofactor for ten-eleven translocation (TET) methyl-
cytosine dioxygenases responsible for DNA demethylation. TETs
belong to the Fe(II) and 2-oxoglutarate (2OG, alternatively termed
α-ketoglutarate)–dependent dioxygenase superfamily.Without Fe(II),
the reaction catalyzed by these dioxygenases would be halted
(Tahiliani et al, 2009). However, Fe(II) is tightly controlled in the cell
largely because of its ability to produce free radicals through the
Fenton reaction (Dunn et al, 2007). We showed that elevation of
intracellular cAMP increases the intracellular labile Fe(II) pool, which
further enhances DNA hydroxymethylation and changes the tran-
scriptome (Camarena et al, 2017). Thus, environmental factors, by
stimulating Gs-/Gi-coupled receptors or by directly affecting the
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activity of AC/PDE, could alter the intracellular labile Fe(II) pool, DNA
methylation, and gene transcription via the secondmessenger cAMP.
JmjC domain–containing histone demethylases, such as TETs, also
belong to the Fe(II) and 2OG–dependent dioxygenase superfamily,
indicating that labile Fe(II) is essential for JmjC-mediated histone
demethylation (Tsukada et al, 2006). This raises a possibility that
cAMP signaling might also regulate histone demethylation. Here, we
report that activation of Gs-coupled receptors caused a rapid loss of
histone methylation, especially H3K4me3, an effect that was mim-
icked by cAMP analogues and forskolin but was blocked by AC in-
hibition. Conversely, stimulation of Gi-coupled receptors quickly
elevated H3K4me3, which is inhibited by forskolin. The effect of cAMP
signaling on H3K4me3 was mediated by labile Fe(II) and was blocked
by iron chelators. In the absence of Fe(III) in the medium, activation
of Gs-coupled receptors no longer augmented the intracellular labile
Fe(II) pool. Knockout of Rap guanine nucleotide exchange factor-2
(RapGEF2) abolished the effect of cAMP signaling on vacuolar H+-
ATPase assembly, endosome acidiﬁcation, and subsequent intracel-
lular labile Fe(II) elevation. Upon ligand removal, H3K4me3 gradually
recovers towards baseline levels. Collectively, this study may provide
insight into the regulation of histonedemethylation by cAMP signaling,
which could be implicated in human health and disease.
Results
cAMP rapidly and speciﬁcally reduces H3K4 methylation
We previously reported that intracellular cAMP elevation induces
DNA demethylation in a variety of cell types by augmenting the
intracellular labile Fe(II) pool (Camarena et al, 2017). Since JmjC
domain-containing histone demethylases require Fe(II) as an es-
sential cofactor, we speculated if cAMP could also alter histone
demethylation. To test this hypothesis, we treated cultured
Schwann cells with membrane-permeable cAMP analogue 8-CPT-
cAMP (hereafter denoted as cAMP) and assessed levels of four
well-characterized histone 3 (H3) trimethylation marks: H3K4me3,
H3K9me3, H3K27me3, and H3K36me3. Prolonged cAMP treatment
(8–48 h) led to a reduction in H3K4me3, but not other trimethylation
marks (Fig 1A and B). A comparable change in H3K4me3 was also
observed using immunoﬂuorescence (IF) (Fig S1). Our existing
RNA-seq data revealed that the top three highly expressed JmjC
domain-containing histone demethylases in Schwann cells are
KDM5A, KDM5B, and KDM5C, which preferentially demethylate H3K4.
In comparison, the level of KDM5 expression is 3.2–47.5-fold of other
KDMs (Table S1), which may explain at least partially that cAMP
Figure 1. cAMP decreases H3K4 trimethylation.
(A) Immunoblot of histone trimethylation marks in
Schwann cells treated with membrane-permeable
8-CPT-cAMP (100 μM) for various times. (B) Band density
quantiﬁcations show that cAMP treatment reduces
H3K4me3 but not H3K9me3, H3K27me3, or H3K36me3 in
Schwann cells (n = 3). (C) IF of H3K4me3 after cAMP (50 μM)
treatment followed by washout. (D) Quantiﬁcation of IF
shows that H3K4me3 is markedly decreased 30 min after
washout, which rebounds towards baseline levels
after 3 h 30 min (n > 250 data points per condition).
(E) Immunoblot of H3K4 methylation marks in Schwann
cells after cAMP (50 μM) treatment followed by washout.
(F) Band density quantiﬁcations show that unlike
H3K4me3, which decreases then recovers towards
baseline levels, H3K4me2 and H3K4me1 are reduced but
without obvious recovery towards the baseline after
3 h 30 min washout after treatment (n = 3). *P < 0.5,
**P < 0.01. Statistical differences were determined
by one-way ANOVA. All data are means ± SD.
Scale bar = 20 μm.
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signaling causes a signiﬁcant decrease in H3K4me3 in Schwann
cells compared with other methylated histone marks.
Intracellular cAMP levels vary according to cell type, ranging from
10 nM to 10–50 μM after stimulation of Gs-coupled receptors (Conti
et al, 2014). Because the cellular permeability of 8-CPT-cAMP is ~20%
(Werner et al, 2011), treatment with 100 μM 8-CPT-cAMP can increase
intracellular cAMP to ~20 μM, which is within the endogenous range.
We next tested if alterations in endogenous cAMP affect H3K4me3.
Treatment with AC activator forskolin and PDE inhibitors caffeine and
3-isobutyl-1-methylxanthine (IBMX), all agents that increase intra-
cellular cAMP, caused rapid loss of H3K4me3 (Fig S2). These results
suggest that cAMP speciﬁcally reduces global H3K4me3 in Schwann
cells and that continuous cAMP treatment maintains this status.
We then focused on H3K4me3 by ﬁrst testing how quickly
H3K4me3 was altered upon cAMP treatment. cAMP inducedmaximal
H3K4me3 demethylation as early as 30min of continuous treatment
(Fig S3). Intracellular cAMP often oscillates under physiological
conditions (Dyachok et al, 2006). To mimic this condition, the cells
were brieﬂy treated with cAMP which was subsequently removed by
washout and medium change. Although short (30 min) treatment
with cAMP reduced H3K4me3, levels of H3K4me3 appeared to re-
bound back towards baseline 3 h 30 min after washout (Fig 1C and
D). We also tested A2058 melanoma cells which, like Schwann cells,
are of neural crest origin and may express similar JmjC domain–
containing histone demethylases and, therefore, exhibit H3K4me3
demethylation upon cAMP treatment. The rapid reduction inH3K4me3,
but not other trimethylation marks, was also observed in A2058
cells along with a swift recovery towards baseline levels after cAMP
removal (Fig S4). Collectively, these results suggest that cAMP
quickly triggers a global reduction in H3K4me3, which is not limited
to Schwann cells but is likely a general effect of cells that express
similar demethylase proﬁles.
To assess global changes in H3K4 methylation after cAMP
stimulation, we then measured H3K4me2 and H3K4me1. Compar-
atively, both H3K4me2 and H3K4me1 only slightly decreased upon
cAMP treatment. Unlike H3K4me3, after removal of cAMP for 3 h 30
min, H3K4me2 and H3K4me1 levels remained low without obvious
recovery towards baseline levels (Fig 1E and F). These data show
that methylation at H3K4, especially H3K4me3, ﬂuctuates rapidly
and dynamically in response to cAMP.
Gs-/Gi-coupled receptors regulate H3K4me3
The signaling of Gs- or Gi-coupled receptors is mainly mediated by
cAMP, the second messenger. These receptors either increase in-
tracellular cAMP by activating AC or decrease intracellular cAMP by
inhibiting AC. We reasoned that because H3K4me3 decreases upon
elevation of intracellular cAMP after treatment with membrane-
permeable cAMP, AC activators, and PDE inhibitors, then perhaps
GPCRs may also regulate H3K4me3. We ﬁrst tested Gs-coupled
calcitonin gene-related peptide (CGRP) receptors that have been
shown to elevate intracellular cAMP in Schwann cells (Cheng et al,
1995). We found that stimulation with CGRP dose-dependently
decreased H3K4me3 (Fig S5). Brief stimulation with CGRP (30
min) followed by washout caused a reduction in H3K4me3 30 min
after washout (Fig 2A and C). Similar to exogenous cAMP treatment,
H3K4me3 levels began to rebound towards the baseline after
washout for 3 h 30 min. The reduction of H3K4me3 was also ob-
served after stimulation of β-adrenergic receptor, another Gs-
coupled receptor expressed in Schwann cells (Fig S6). To test if
cAMP indeed mediated the effect of Gs-coupled receptors on
H3K4me3, an AC inhibitor was applied before agonist stimulation.
Treatment with AC inhibitor SQ22536 abolished the reduction of
H3K4me3 induced by CGRP or isoproterenol and H3K4me3 levels
rebounded even higher than the baseline after ligand removal for
3 h 30 min (Figs 2A and C, and S6). These results suggest that Gs-
coupled receptors, via cAMP, rapidly reduce H3K4me3.
If Gs-coupled receptors reduce H3K4me3 by up-regulating in-
tracellular cAMP, Gi-coupled receptors could conversely increase
H3K4me3 by down-regulating intracellular cAMP. We then tested Gi-
coupled lysophosphatidic acid receptors (LPAR1 and LPAR3), which
have been shown to diminish intracellular cAMP in Schwann cells
(Anliker et al, 2013). LPA treatment (1 h) caused an increase in
H3K4me3 after washout for 1 h. The level of H3K4me3 consequently
declined towards the baseline after washout for 3 h (Fig 2B and D).
Furthermore, pretreatment with the AC activator forskolin hindered
the effect of LPA on H3K4me3 (Fig 2B and D), suggesting that Gi-
coupled receptors, via cAMP, quickly increase H3K4me3. Taken
together, these data suggest that Gs-/Gi-coupled receptors regu-
late H3K4me3.
Rapid labile Fe(II) elevation underpins cAMP-induced H3K4me3
demethylation
JmjC-mediated histone demethylation requires the following
components: the enzyme JmjC domain–containing histone deme-
thylases (various kinds expressed in most cells), the substrate-
methylated lysine in histones (abundant in the chromatin), the
cofactor Fe(II), the co-substrate 2OG (abundant in healthy cells),
and oxygen (accessible to cultured cells). Of all these components,
Fe(II) is tightly controlled in the cell because of its ability to produce
free radicals through the Fenton reaction (Dunn et al, 2007). Given
the observation that H3K4me3 is rapidly altered by cAMP signaling
(within 1 h), new protein synthesis is unlikely to participate in this
regulation. Our earlier work shows that cAMP promotes TET-mediated
DNA demethylation by elevating labile Fe(II) (Camarena et al, 2017),
which was measured by Trx-Puro probes (Spangler et al, 2016) after
cAMP analogue or GPCR ligand treatment for more than 3 h. It is
plausible that the effect of cAMP on histone demethylation is also
mediated by labile Fe(II). However, it is unclear if cAMP can induce a
rapid change in labile Fe(II).
We used a newly developed FIP-1 probe to measure intracellular
labile Fe(II) after cAMP stimulation. This probe is a highly sensitive
Fe(II) sensor which uses ﬂuorescence resonance energy transfer
(FRET) to measure changes in labile Fe(II) in real time using mi-
croscopy (Aron et al, 2016). cAMP stimulation for 30min induced anear
20% peak increase in labile Fe(II) (Fig 3A and B). Levels of labile Fe(II)
began to decline to the baseline after washout for 1 h. The transient
elevation of labile Fe(II) caused by brief cAMP treatment is correlated
with H3K4me3 reduction induced by the same treatment. Further-
more, LPA treatment, via Gi-coupled LPAR1 and LPAR3, diminished
intracellular labile Fe(II) (Fig S7), which is also associated with
H3K4me3up-regulation. These results indicate a dynamic relationship
between levels of cAMP and the intracellular labile Fe(II) pool.
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We then tested whether elevated labile Fe(II) mediates the effect
of cAMP on H3K4me3. Fe(II), which is scarce in the extracellular
milieu in vivo, can directly enter into the cell through divalent metal
cation transporter 1 (DMT1) (De Domenico et al, 2008). The addition
of Fe(II) to the cell media resulted in a time-dependent decrease in
H3K4me3 levels (Fig 3C and D). Conversely, the addition of iron
chelators 2,2 bipyridyl and deforexamine before cAMP stimulation
abolished the effect of cAMP on H3K4me3 (Fig 3E). Overall, these
data suggest that cAMP rapidly elevates the intracellular labile
Fe(II) pool, which consequently induces H3K4me3 demethylation.
The canonical cAMP signaling involves PKA, cyclic nucleotide-gated
channels (CNGCs), and exchange protein directly activated by cAMP
(Epac) (Gloerich&Bos, 2010). To assesswhether these canonical targets
of cAMP underlie cAMP-mediated demethylation of H3K4me3, we
pretreated cells with the Epac inhibitor ES109, PKA inhibitors KT5720 and
H89, or CNGC blocker l-cis-diltiazem. Pretreatment with any of these
inhibitors and blocker did not sufﬁciently block cAMP-mediated
H3K4me3 reduction (Fig S8). This is consistent with our previous re-
port that cAMP elevates labile Fe(II) via a non-canonical pathway.
Collectively, our data suggest that cAMP induces H3K4me3 demethy-
lation by augmenting the intracellular labile Fe(II) pool and that this
phenomenon occurs independently of the canonical cAMP signaling
pathway.
cAMP signaling elevates labile Fe(II) via RapGEF2-dependent
V-ATPase assembly
Intracellular labile Fe(II) is largely governed by Fe(III) uptake from
the extracellular space and subsequent reduction to Fe(II) in the
endosome. We, therefore, tested whether extracellular Fe(III) was
required for cAMP-induced intracellular Fe(II) elevation. In the ab-
sence of Fe(III) in the media, isoproterenol, a ligand for Gs-coupled
β-adrenergic receptors which increase intracellular cAMP, no longer
elevated intracellular labile Fe(II) in Schwann cells (Fig 4A), sug-
gesting that cellular iron uptake is indeed involved in the up-
regulation of Fe(II) by cAMP signaling.
Fe(III) is internalized via transferrin–transferrin receptor-mediated
endocytosis, which localizes to the endosome. There, endosome
acidiﬁcation by the vacuolar H+-ATPase (V-ATPase) causes release
of Fe(III) from transferrin and is subsequently converted to Fe(II)
(Nishi & Forgac, 2002). We previously showed that cAMP signaling
enhances endosome acidiﬁcation and that silencing of RapGEF2, a
non-canonical target of cAMP, abolishes the effect of cAMP on
endosome acidiﬁcation and labile Fe(II) (Camarena et al, 2017).
However, it remains largely unclear how cAMP signaling affects the
acidiﬁcation of endosomes. It is plausible that cAMP signaling may
induce endosome acidiﬁcation by affecting the function or the
Figure 2. GPCR stimulation alters H3K4
trimethylation.
(A) IF of H3K4me3 after CGRP (10 nM) treatment for 30
min followed by washout, with or without pretreatment
of AC inhibitor SQ22536 (100 μM). (B) IF of H3K4me3
after LPA (2 μM) treatment for 1 h followed by washout,
with or without pretreatment of AC activator forskolin
(10 μM). (C) Quantiﬁcation of IF shows that brief
stimulation with Gs-coupled receptor ligand CGRP
followed by washout induces peak demethylation of
H3K4me3 at 30 min after washout. Pretreatment with
SQ22536 abolishes CGRP-induced H3K4me3 reduction
(n > 250 data points per condition). (D) Quantiﬁcation of
IF shows that stimulation with Gi-coupled receptor
ligand LPA (2 μM) followed by washout promotes
massive H3K4 trimethylation 1 h after washout which
retreats towards baseline levels after 3 h.
Pretreatment with forskolin abrogates LPA-induced
H3K4 trimethylation 1 h after washout (n > 250 data
points per condition). *P < 0.5, **P < 0.01. Statistical
differences were determined by two-way ANOVA. All
data are means ± SD. Scale bar = 20 μm.
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assembly of V-ATPase. We tested if cAMP signaling changes V-ATPase
assembly by assessing V-ATPase subunit V1A abundance in
endosome-enriched cellular fractions as a measure of assembly
and V0D as a loading control (McGuire & Forgac, 2018). RapGEF2
knockout neuroscreen-1 (NS1-RapGEF2 KO) cells and the wild-type
NS-1 (NS1-WT) control cells were used in this experiment (Emery
et al, 2013; Jiang et al, 2017). We found that forskolin treatment
induced massive up-regulation of V-ATPase subunit V1A in the
membrane fraction of NS1-WT cells, indicating increased V-ATPase
assembly. The enhanced V-ATPase assembly was veriﬁed in HEK-
293 cells after treatment with isoproterenol (Fig S9). However,
forskolin-induced V-ATPase assembly was attenuated in RapGEF2
knockout NS1 cells (NS1-RapGEF2 KO) cells (Fig 4B). These results
suggest that cAMP signaling promotes V-ATPase assembly and is
likely dependent on RapGEF2.
By ablation of cAMP-induced V-ATPase assembly, knockout of
RapGEF2 could further impair endosome acidiﬁcation. Indeed, we
found that deletion of RapGEF2 abolished forskolin-induced en-
docytotic vesicle acidiﬁcation compared with the wild-type cells
(NS1-WT) (Fig 4C). It is known that Fe(II) release from the endosome
into the intracellular labile Fe(II) pool relies on endosome acidi-
ﬁcation. In wild-type cells, forskolin treatment up-regulated labile
Fe(II). In contrast, the same treatment failed to increase labile Fe(II)
in RapGEF2 knockout cells (Fig 4D). Similarly, treatment with Gs-
coupled ligands isoproterenol or CGRP induces up-regulation of
labile Fe(II) in NS1-WT cells, whereas this effect was abolished in
cells lacking RapGEF2 (Figs 4E and FigsS10). Collectively, these data
suggest that cAMP induces RapGEF2-dependent V-ATPase as-
sembly which consequently up-regulates endosome acidiﬁcation
and labile Fe(II)—the cofactor for JmjC domain–containing histone
demethylases.
Rapid H3K4me3 demethylation and subsequent recovery are
mediated by KDM5 and histone methyltransferases (HMTs)
The dynamics of H3K4me3 are governed by the activities of HMTs
and JmjC domain–containing demethylases. Again, we probed
our existing RNA-seq data and found that the top three highest
expressed JmjC domain–containing histone demethylases in
Schwann cells are KDM5A, KDM5B, and KDM5C, which preferentially
demethylate H3K4 (Table S1) (Brier et al, 2017). It could be that KDM5
is responsible for the rapid decrease of H3K4me3 caused by cAMP
signaling. To test this hypothesis, we pretreated Schwann cells with
Figure 3. Intracellular labile Fe(II) mediates
cAMP-induced H3K4me3 demethylation.
(A) Live imaging of Schwann cells pretreated with the
Fe(II)-sensitive FIP-1 probe and brieﬂy treated with
cAMP (100 μM) followed by washout. Images
represent the ratio of the Fe(II) channel/FRET channel
(pseudo-colored red/yellow). Increased red/yellow
signal indicates an increase in intracellular Fe(II).
(B) Fluorescence quantiﬁcation shows that cAMP
treatment induces a peak increase of labile Fe(II) 30 min
after washout which dissipates within 1 h (n > 250
data points per condition). (C) IF of H3K4me3 after
Fe(II) sulfate (0.1 μM) treatment for various times.
(D) Quantiﬁcation of IF shows that Fe(II) sulfate
decreases H3K4me3 in a time-dependent manner (n >
250 data points per condition). (E) Pretreatment with
iron chelators 2,2 bipyridyl and deforexamine (20 μM)
abolishes cAMP-induced H3K4me3 demethylation. *P <
0.5, **P < 0.01. Statistical differences were determined by
one-way ANOVA. All data are means ± SD. Scale bar =
20 μm.
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a pan KDM5 inhibitor KDOAM-25. Without KDOAM-25 pretreatment,
short-term cAMP treatment causes a rapid reduction in H3K4me3 at
30 min after washout which rebounds towards baseline levels after
3 h 30 min. In comparison, pretreatment with KDOAM-25 completely
abolished the effect of cAMP on H3K4me3 (Fig 5A and C). We then
used siRNA silencing of KDM5A/B/C isoforms to further validate
their role in cAMP-induced H3K4me3 demethylation. cAMP caused
signiﬁcant H3K4me3 demethylation in Schwann cells, provided no
siRNA or treated with non-targeting (Scramble) siRNA. However,
treatment with KDM5 siRNA abolished cAMP-induced H3K4me3
demethylation (Fig S11). Considering that the expression of KDM5
remains relatively unchanged after cAMP treatment (Camarena
et al, 2017), these results suggest that upon brief cAMP signaling
and subsequent transient labile Fe(II) up-regulation, the cata-
lytic activity of KDM5 is enhanced and H3K4me3 is subsequently
demethylated.
To test whether HMTs underlie the rebound of H3K4me3 after
cAMP washout, we pretreated cells with a cocktail consisting of
HMT inhibitors MI-2 and MM-102 before brieﬂy treating cells with
cAMP and following up with washout. Without HMT inhibitors,
H3K4me3 rebounds towards baseline levels 3 h 30 min after
washout (Fig 5B and D). In contrast, pretreatment with HMT in-
hibitors abolishes the rebound of H3K4me3 and prolongs cAMP-
induced H3K4me3 demethylation after washout (Fig 5B and D),
suggesting that HMTs are responsible for H3K4me3 recovery after
cAMP-induced H3K4me3 demethylation. Overall, upon activation
of cAMP signaling, KDM5 and HMTs work cooperatively in tandem
to dynamically regulate H3K4me3, which could consequently alter
transcription.
cAMP induces H3K4me3 demethylation mostly within promoter
regions
To further understand the impact of cAMP signaling on H3K4me3 in
the chromatin, we performed ChIP-seq on Schwann cells brieﬂy
treated with cAMP followed by washout. Consistent with the im-
munoblot results, cAMP treatment induces a widespread reduction
of H3K4me3 peaks 30min after washout followed by a restoration of
H3K4me3 after 3 h 30 min (Fig 6A). Differential peak analysis showed
that 1,391 peaks were down-regulated and 856 peaks were up-
regulated at 30 min, resulting in an observed net decrease in
H3K4me3. Although a trend was observed, differential peak analysis
found that 2,364 peaks were down-regulated and 2,277 peaks were
up-regulated at 3 h 30 min, resulting in no net increase at 3 h 30min
likely because of the high variability between samples in this
condition. About 50% of all H3K4me3 peaks are down-regulated 30
min after washout, which are restored after 3 h 30 min (Table S2).
Interestingly, more than 90% of all called peaks are in the same
locations across all three time points (Fig 6B), suggesting that the
major changes after cAMP stimulation occur at the same loci.
Furthermore, H3K4me3 was found to be highly enriched in gene
promoter regions with more than 50% of all H3K4me3 promoter
Figure 4. cAMP-induced Fe(II) elevation is likely
mediated by RAPGEF2 and endosome acidiﬁcation.
(A) IF of labile Fe(II) using TRX-Puro ferrous iron probe
in Schwann cells cultured in media containing Fe(III) or
media without Fe(III) then treated with Gs-coupled
receptor ligand isoproterenol (10 μM). Scale bar = 20
μm. (B) Immunoblot of V-ATPase subunits V1A and V0D in
wild-type NS1 cells (NS1-WT) and RapGEF2 knockout
cells (NS1-RapGEF2 KO) treated with forskolin (100 μM).
Band density quantiﬁcations of the relative ratio
between V1A and V0D show that forskolin treatment
promotes vATPase assembly in NS1-WT cells but is
ablated in NS1-RapGEF2 KO cells. (C) Fluorescence-
based vesicular pH probe signal after forskolin (100
μM) treatment in NS1-WT and NS1-RAPGEF2 KO cells.
Red ﬂuorescence increases when the pH decreases
from 8 to 4. Scale bar = 40 μm. Boxes enclose high
magniﬁcation images of cells and endocytotic vesicles.
Scale bar = 100 μm. (D) IF of labile Fe(II) using TRX-Puro
ferrous iron probe in NS1-WT and RAPGEF2 KO cells
after forskolin (100 μM) treatment. Scale bar = 10 μm.
(E) IF of labile Fe(II) using TRX-Puro ferrous iron probe in
NS1 WT and RAPGEF2 KO cells after treatment with
isoproterenol. Scale bar = 10 μm.
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peaks down-regulated 30 min after washout which subsequently
return to baseline levels after 3 h 30 min (Fig 6C and Table S3). This
effect was seen genome-wide in a diverse set of genes, including
Samd1, Fpgt, and many others (Fig 6D and Tables S4, and S5).
Overall, our data reveal a novel cAMP signaling pathway which
connects periodic GPCR signaling with rapid changes in histone
methylation (Fig 7).
Discussion
Posttranslational modiﬁcation of histones by methylation is dy-
namic and reversible, which plays critical roles in development and
disease (Greer & Shi, 2012). It is known that certain environment
factors, such as dietary consumption of methionine—the precursor
of methyl donors—could change the status of histone methylation
(Mentch et al, 2015). However, besides methionine metabolism, it
remains elusive if and how numerous extracellular molecules af-
fect histone methylation. Membrane receptors such as GPCRs, the
largest andmost diverse receptor family, sense environmental cues
by binding with ligands (Sutherland, 1970). The binding of GPCRs
with corresponding ligands triggers intracellular signaling. cAMP is
the second messenger of numerous Gs- or Gi-coupled receptors,
which upon stimulation increase or decrease intracellular cAMP,
respectively. Under physiological conditions, the agonists for GPCRs
are often persistent and periodic. Consequently, the level of in-
tracellular cAMP oscillates, like waves (Dyachok et al, 2006). In the
current study, we show that transient elevation of intracellular
cAMP, by brief stimulation of Gs-coupled receptors or short ex-
posure to membrane-permeable cAMP, causes wave-like changes
in H3K4me3—a rapid reduction followed by recovery towards
baseline levels. Comparatively, transient reduction of intracellular
cAMP by quick stimulation of Gi-coupled receptors initiates an
opposite, yet similar wave-like change in H3K4me3—a rapid ele-
vation followed by recovery towards baseline levels. Collectively,
our data suggest that extracellular GPCR stimulation via cAMP
oscillates with H3K4me3 in the chromatin.
The rapid ﬂuctuation of H3K4me3 by GPCRs appears to be me-
diated by labile Fe(II), an essential cofactor for JmjC domain–
containing demethylases. JmjC domain–containing demethylases
contain more than 20 members and can remove methyl group from
tri-, di-, and monomethylated histone lysine residues (Justin et al,
2010). Without any stimulation, baseline H3K4me3 remains rela-
tively stable. When Fe(II) is added to the media and enters the
intracellular labile Fe(II) pool, methylation at H3K4 especially
H3K4me3 is rapidly decreased, suggesting that intracellular labile
Figure 5. KDM5 demethylases and histone
methyltransferases underlie H3K4me3 dynamics
after cAMP treatment.
(A) IF of H3K4me3 after 8-CPT-cAMP (50 μM) treatment
for 30 min followed by washout, with or without
pretreatment of KDM5 inhibitor KDOAM-25 (100 μM).
(B) IF of H3K4me3 after 8-CPT-cAMP (50 μM) treatment
for 30 min followed by washout, with or without
pretreatment of HMT inhibitors MI-2 (20 μM) and
MM-102 (20 μM). (C) Quantiﬁcation of IF shows that brief
treatment with cAMP followed by washout induces
peak demethylation of H3K4me3 30 min after washout.
Pretreatment with pan KDM5 demethylase inhibitor
KDOAM-25 abolishes the effect of cAMP on H3K4me3
(n > 250 data points per condition). (D)Quantiﬁcation of
IF shows that pretreatment with HMT inhibitors MI-2 and
MM-102 blocks the restoration of H3K4me3 after 3 h
30 min and slightly hinders cAMP-induced H3K4me3
demethylation at 30 min after washout (n > 250 data
points per condition). *P < 0.5, **P < 0.01. Statistical
differences were determined by two-way ANOVA. All
data are means ± SD. Scale bar = 20 μm.
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Fe(II) promotes the catalytic activity of KDM5, which is highly
expressed in Schwann cells and antagonizes H3K4 methylation.
Our earlier work showed that cAMP signaling regulates the intra-
cellular labile Fe(II) pool through a previously unrecognized pathway
involving the noncanonical cAMP target RapGEF2, Rap1 activation,
endosome acidiﬁcation, and subsequent labile Fe(II) release from
the endosome (Camarena et al, 2017). We now show that cAMP
signaling up-regulates labile Fe(II) via iron cellular uptake. Our
results further demonstrate that cAMP enhances the assembly of
the V-ATPase, which is responsible for pumping protons into
endosomes. Using RapGEF2 null cells, we consolidate that RapGEF2
is essential in the up-regulation of endosome acidiﬁcation and
subsequent labile Fe(II) release by cAMP signaling. It is, thus,
plausible that cAMP targets RapGEF2, which activates Rap1 and in
turn promotes V-ATPase assembly. This warrants further detailed
studies in the future.
Treatment with cAMP or Fe(II) caused widespread demethylation
of H3K4me3 but not other trimethylated histone marks. This could
be due to a relatively higher expression of KDM5, which antagonizes
H3K4 methylation, in Schwann cells. Our existing RNA-seq data
revealed that the highest expressed JmjC domain–containing
histone demethylases in Schwann cells are KDM5A, KDM5B, and
KDM5C, with a combined expression that is 3.2–47.5-fold higher than
other KDMs (Table S1). Increased expression of KDM5 could,
therefore, explain widespread H3K4me3 demethylation in response
to Fe(II) elevation. In addition, H3K4me3 has the highest turnover
rate of any trimethylation mark with a half-life of 6 h 48 min (Zheng
et al, 2014). It has been posited that this could be due to either (1) an
increased basal activity of JmjC domain–containing demethylases
which target H3K4me3 or (2) transcription-dependent eviction of
nucleosomes near the transcription start site which are enriched in
H3K4me3. Furthermore, restriction of methionine, the methyl donor
for methyltransferases, in both cells and mice causes a drastic
reduction in H3K4me3 compared with other trimethylated histone
marks (Mentch et al, 2015; Dai et al, 2018). Although future studies
are warranted to elucidate mechanistic processes underlying
H3K4me3 turnover, these observations suggest that H3K4me3 is
relatively unstable and may, therefore, be more sensitive to
Figure 6. ChIP sequencing reveals that cAMP induces
rapid, widespread changes in H3K4me3.
(A) Heat map of all detected H3K4me3 peaks after brief
cAMP (50 μM) treatment followed by washout. (B) Chart
representing the percentage of peaks called in one
condition, two conditions, or all conditions. A vast
majority of peaks were called from the same location in
every condition. (C) Brief treatment with cAMP (50
μM) followed by washout induces peak demethylation
of H3K4me3 at promoter regions 30 min after washout.
(D) Representative H3K4me3 peaks from Samd1 and
Fpgt which exhibited H3K4me3 demethylation 30 min
after washout and recovery of H3K4me3 after 3 h 30 min.
Plots were created using Integrative Genomics
Viewer. Peak coordinates are indicated in gray. n = 3 for
ChIP sequencing experiment.
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demethylation upon cAMP-induced Fe(II) elevation compared with
other histone marks.
Continuous treatment with cAMP or stimulation of Gs-coupled
receptors elevates intracellular labile Fe(II). To mimic the physiological
oscillation of intracellular cAMP, we treated cells in this study
brieﬂy with cAMP which induced a relatively transient increase of
intracellular labile Fe(II) followed by a decline towards the
baseline after washout. The rapid wave-like change in the labile
Fe(II) pool correlates inversely with the wave form pattern in
H3K4me3 after cAMP treatment and washout. When iron chelators
are applied, intracellular cAMP elevation no longer induces any
changes in H3K4me3. Thus, periodic activation of GPCRs could
constantly change H3K4me3 through oscillations in intracellular
cAMP, concurrent ﬂuctuations in labile Fe(II), and subsequent
changes in KDM5 activity. Cells are constantly exposed to a barrage
of extracellular stimuli and must dynamically respond to them to
Figure 7. Working model of cAMP-induced H3K4me3
demethylation.
Activation of Gs-coupled receptors leads to a transient
increase in cAMP, the second messenger, which results
in RapGEF-mediated V-ATPase assembly and
endosome acidiﬁcation. Acidiﬁcation causes release of
Fe(III) from transferrin–transferrin receptor complex
and is converted to Fe(II) by Steap3 before leaving
the endosome and elevating the labile Fe(II) pool.
Increased intracellular labile Fe(II) leads to increased
activity of KDM5 demethylases and results in
transient demethylation of H3K4me3.
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function and survive. cAMP-induced histone demethylation via
GPCR activation could be a signaling mechanism used by the cell to
swiftly alter transcription in response to a dynamically changing
microenvironment. Using cAMP, the evolutionarily conserved second
messenger, repurposes an intracellular process that is not only rapid
but also responsive to a diversity of extracellular stimuli which ac-
tivate GPCRs, thus conferring a more nuanced cellular response to
dynamic environmental challenges.
The dynamic ﬂuctuation of histone lysine methylation modu-
lates chromatin structure, genome stability, and ultimately gene
transcription (Klose et al, 2006). Our study indicates that this
process is also coordinated in response to cAMP signaling. Histone
methylation at different lysine residues leads to diverse conse-
quences in transcription. H3K4me3, especially when located in the
promoter region, is associated with actively transcribed genes
(Santos-Rosa et al, 2002; Guenther et al, 2007; Heintzman et al, 2007).
By ChIP-seq, we conﬁrmed that genome-wide H3K4me3 decreases
upon treatment with cAMP and recovers towards the baseline after
cAMP removal. Changes in H3K4me3 peaks detected by ChIP-seq
were relatively modest compared with results obtained via IF or
Western blot for overall H3K4me3. It is not exactly clear to us why
only modest changes were discovered in the ChIP-seq analysis. We
found that very high percentage of reads reside within large peaks,
whichmay consequently affect the read coverage in other relatively
smaller peaks that could be altered by the treatment. This read
coverage bias towards large peaks may explain the relatively
modest changes by ChIP-seq analysis. Although the fold changes
detected in the genomic analysis are modest, they were found to be
statistically signiﬁcant and may nonetheless be biologically rele-
vant to transcription. H3K4me3 is known to be co-transcriptionally
deposited (Woo et al, 2017). Although H3K4me3 is classically as-
sociated with the promoters of transcriptionally active genes, it
remains unclear whether cAMP-induced H3K4me3 is a conse-
quence or a determinant of the differentially transcribed genes. It is
known that cAMP has an impact on transcription (Montminy, 1997).
Currently, it is believed that PKA-dependent phosphorylation of the
transcription factors cAMP response element-binding protein
(CREB), cAMP response element modulator (CREM), and activating
transcription factor (ATF) are principally responsible for changes in
gene expression after cAMP signaling. However, our data show an
alternative mechanism, whereby cAMP signaling induces swift
changes in labile Fe(II) to alter KDM activity and subsequently cause
rapid changes in H3K4me3, which could potentially alter tran-
scription independently of PKA and other canonical cAMP targets.
Furthermore, we previously reported that cAMP signaling could
affect the transcriptome by DNA demethylation (Camarena et al,
2017). Now it is likely that GPCRs, via cAMP signaling, may regulate
gene transcription through three mechanisms: PKA-dependent
transcription factors, DNA methylation, and histone methylation.
Future studies are warranted to dissect how cAMP signaling co-
ordinates these three mechanisms in gene transcription.
By regulating the intracellular labile Fe(II) pool, GPCRs via cAMP
affect demethylation of both DNA and histones. Because Fe(II) is
tightly controlled within the cell (Dunn et al, 2007), there could be
a competition between TET-mediated DNA demethylation and
JmjC-mediated histone demethylation. It is unclear if and how
histone demethylation interacts with DNA demethylation under
the inﬂuence of cAMP signaling. In this study, we mainly examined
primary cultured Schwann cells which are not plagued by mu-
tations as in most cell lines. Furthermore, these cells grow slowly
which allows us to examine the impact of GPCRs on histone
methylation without frequent cell cycle interference. The regu-
lation of histone demethylation could be a general effect of cAMP
signaling, as the suppression of H3K4me3 by cAMP was also
veriﬁed in A2058 melanoma cells. A2058 cells, like Schwann cells
and melanocytes, are of neural crest origin and may share similar
JmjC domain–containing histone demethylase expression proﬁles,
which could explain why H3K4me3 is preferentially demethylated in
both cell types. Because all JmjC domain–containing histone
demethylases use Fe(II) for demethylase activity, it is expected
that cAMP signaling would ﬂuctuate different histone marks
depending on the JmjC histone demethylase expression proﬁle of a
given cell type. Furthermore, nearly 50% of all marketed drugs
target various GPCRs, many of which are transduced through cAMP
signaling. However, the impact of these drugs on the demethylation
of DNA and histones has been overlooked. Other agents such as
caffeine in beverages and bicarbonate, the baking soda, could
change the epigenome by directly elevating intracellular cAMP.
These drugs and agents may exert a long-lasting impact on human
health, disease, and even inheritance through epigenetic mecha-
nisms which are just now being elucidated.
In conclusion, GPCRs regulate JmjC-mediated histone deme-
thylation through cAMP signaling and intracellular labile Fe(II). This
previously unrecognized function of cAMP signaling could have
wide-reaching implications in human health and disease.
Materials and Methods
Cell culture
Primary cultured Schwann cells were isolated from 3-mo-old
Fisher rat sciatic nerves as previously described (Monje, 2018).
Brieﬂy, nerves were cut into small segments, incubated in vitro
for 10 d in DMEM medium containing 10% heat-inactivated FBS
and allowed to degenerate. Degenerated nerve explants were
dissociated using a 0.25% dispase/0.05% collagenase solution
and the resulting cell suspension was plated on poly-L-lysine-
coated dishes (Sigma-Aldrich). Puriﬁed primary Schwann cells were
expanded up to passage one in DMEM media containing 10 nM
neuregulin (recombinant heregulin-β1) and 2 μM forskolin. Experi-
ments were performed on Schwann cells between three and six
passages and plated on glass coated with poly-L-lysine and laminin
from Engelbreth-Holm-Swarmmurine sarcoma basementmembrane.
Schwann cells were grown for experiments in DMEM supplemented
with 10% FBS and without neuregulin or forskolin.
For cAMP washout experiments, Schwann cells were treated with
8-CPT-cAMP (8-(4-chlorophenylthio) adenosine-39,59-cyclic mono-
phosphate) for 30 min, washed quickly with PBS, and then given new
DMEM media. The cells were collected at the following time points
after washout: 0 (30 min of treatment, collect without washing), 30
min (30 min of treatment, wash, replace media, and collect after 30
min), and 3 h 30 min (30 min of treatment, wash, replace media, and
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collect after 3 h 30min). For experiments involving inhibitors, all cells
were pretreated and resupplied with the inhibitor following washout.
Immunoblot
After treatment, the cells were washed with PBS and lysed with
radioimmunoprecipitation assay (RIPA) buffer buffer containing
phosphatase and protease inhibitors. Cell lysates were resuspended
in Laemmli SDS sample buffer (60 mM Tris–HCl, 1% SDS, 10% glycerol,
0.05% bromophenol blue, pH 6.8, and 2% β-mercaptoethanol) and
then subjected to 10% SDS–PAGE. The gels were then transferred to
polyvinylidene diﬂuoride (PVDF) membrane for immunoblot. Mem-
branes were then blocked in 5% non-fat skim milk for 1 h and then
incubated with primary antibody at 4° overnight. Primary antibodies
directed against H3K4me3 (Cat. no. 39915; Active Motif), H3K4me2
(Cat. no. 9725; Cell Signaling), H3K4me1 (Cat. no. 9723; Cell Signaling),
H3K9me3 (Cat. no. 39161; Active Motif), H3K27me3 (Cat. no. 39156;
Active Motif), H3K36me3 (Cat. no. 61101; Active Motif), and H3 total
(Cat. no. 39763; Active Motif) were used. Membranes were then
washed three times before incubating with peroxidase-conjugated
secondary antibody. Protein bands were detected using a chem-
iluminescence kit (Millipore).
IF
Cells were seeded onto 24-well plates containing 12-mm glass
coverslips at 10,000–50,000 cells per well. After treatments were
performed, the cells were ﬁxed with 4% PFA, blocked with 5% bovine
serum albumin, and 0.4% Triton X-100 in PBS for 1 h, then incubated
with anti-H3K4me3 primary antibody (Cat. no. 39915; Active Motif,
1:1,000) at 4° overnight. The cells were then incubated with Alexa
Fluor 488–conjugated donkey antirabbit IgG (1:1,000) and coun-
terstained with DAPI.
Image acquisition and analysis
Images from IF experiments were captured using a Zeiss LSM 710
confocal microscope at a bit depth of 8 and into a 512 × 512 frame size.
Fluorescence intensity was quantiﬁed using Fiji (ImageJ) (Schindelin
et al, 2012). Pixel intensity values were averaged 16 times andmeasured
fromevery cell within the image ﬁeld fromaminimumof ﬁve ﬁelds per
condition (~450 cells total). The intensity values from every cell within
the image ﬁeld were plotted and analyzed by one- and two-way
ANOVA with Tukey’s post hoc test and Bonferroni correction using
GraphPad Prism 7 from GraphPad Software.
Intracellular labile Fe(II) detection
Live cell imaging of labile Fe(II) was measured by FIP-1 probe as
previously described (Aron et al, 2016). Brieﬂy, the cells were
washed with HBSS (containing calcium and magnesium) and
incubated with 10 μM FIP-1 in HBSS for 1 h. The cells were washed
three times and maintained in HBSS at 37°C, and live images were
acquired for 30 min every 5 min using a Zeiss laser confocal
microscope 710. The cells were treated with 8-CPT-cAMP (100 μM)
and another 30 min of images were acquired. Media was then
washed three times with HBSS and live images were acquired for
an additional 1 h 30 min. FIP-1 was excited using a 488-nm laser
(“Green” channel and “FRET” channel). “Green” emission was
collected using a META detector between 500 and 535 nm, whereas
“FRET” emission was collected using a META detector between 555
and 611 nm. The ratio of the green channel/FRET channel was
considered as the signal and was pseudo-colored red/yellow.
Analysis and quantiﬁcation were performed using ImageJ. Sta-
tistical analyses for multiple comparisons were carried out
through one-way ANOVA with the Bonferroni correction using the
software R. Labile Fe(II) was also detected using TRX-Puro probes
as described in our previous studies (Spangler et al, 2016;
Camarena et al, 2017).
Vesicular pH detection
Endocytotic vesicle pH was assessed by pHrodo Red Dextran
(Thermo Fisher Scientiﬁc) according to themanufacturer’s protocol.
Brieﬂy, the cells were washed three times with PBS after cAMP or
forskolin treatment and incubated with pHrodo Red Dextran (20 μg/
ml) for 20 min in the incubator at 37°. The cells were then washed
again and ﬁxed with 4% PFA for 10 min. After ﬁxation, the cells were
counterstained with Hoechst 33342 or DAPI. Images were captured
by a Zeiss LSM 710 confocal microscopy.
V-ATPase assembly
This method was performed as previously described (Shao &
Forgac, 2004) with small modiﬁcations. Brieﬂy, 1 × 107 cells were
plated in 10-cm plates. After treatment, the cells were taken to a
4°C cold room and washed twice with ice-cold PBS before col-
lecting in 650 μl of homogenization buffer (250 mM sucrose, 1 mM
EDTA, 10 mM Hepes, 1 mM PMSF, protease inhibitor cocktail
[Sigma-Aldrich], and phosphatase inhibitor cocktail [Thermo
Fisher Scientiﬁc]). The cells were lysed by passing with them
through a 28G syringe ﬁve times. Nuclei and non-fragmented cells
were precipitated by centrifuging at 500g for 10 min. The mem-
brane fraction was precipitated by ultracentrifugation of the
supernatant at 50,000g for 2 h. The cytosolic fraction in the
remaining supernatant was concentrated using Amicon Ultra 10k
centrifugal ﬁlters. The membrane and cytosolic fractions were
resuspended with RIPA buffer (50 mM Tris–HCl, 150 mM NaCl, 0.1%
SDS, 0.5% sodium deoxycholate, and 1% NP40) plus 2% SDS and
protease inhibitors and homogenized with three cycles (30 s On/
OFF at 4°C in high) in a Bioruptor sonitcator (Diagenode). Protein
concentration was determined using the BCA assay (Thermo
Fisher Scientiﬁc). Before SDS–PAGE, cell lysates were resuspended
in SDS sample buffer (60 mM Tris–HCl, 1% SDS, 10% glycerol, 0.05%
bromophenol blue, pH 6.8, with 2% β-mercaptoethanol). Samples
were subjected to 10% SDS–PAGE (Bio-Rad) and transferred to
PVDF membranes (Bio-Rad) for immunoblot. Transfer efﬁciency
was determined by Ponceau S staining (Sigma-Aldrich). PVDF
membranes were incubated with blocking solution (TBS con-
taining 0.1% Tween 20% and 5% milk) and were probed with
speciﬁc antibodies including V1A (H00000523-A01; Abnova, 1:1,000)
and V0D (ab56441; Abcam, 1:1,000). Protein bands were detected using a
chemiluminescence kit (Millipore). Band intensity was quantiﬁed
using Fiji (ImageJ). Relative V-ATPase assembly was determined by
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measuring the ratio between the subunits V1A and V0D in the
membrane and normalized to the ratio found in control samples.
KDM5 siRNA gene silencing
Small short interfering RNA (siRNA) was used to transiently silence
KDM5A, KDM5B, and KDM5C in Schwann cells during cAMP experi-
ments. To decrease the expression of KDM5 isoforms, Accell siRNA
duplexes targeting KDM5A (Cat. no. A-095654-24-0010; Dharmacon),
KDM5B (Cat. no. A-082318-16-0010; Dharmacon), KDM5C (Cat. no.
A-095923-14-0010; Dharmacon), and non-targeting Scramble con-
trol siRNA (Cat. no. D-001910-01-05; Dharmacon) were used. siRNAs
combined and delivered in DMEM containing 2.5% FBS for a ﬁnal
concentration of 1 μM according to the manufacturer’s instructions.
After two 72-h transfections, the cells were treated with cAMP and
collected after 8 h to assess H3K4me3 via IF.
ChIP-seq
Schwann cells were cultured in 150-mm plates until conﬂuency and
chromatin was collected using the ChIP-iT High Sensitivity Kit (Cat.
no. 53040; Active Motif) as instructed by the manufacturer. Brieﬂy,
the cells were ﬁxed with 1% formaldehyde for 15 min, collected via
scraping, and then sonicated using a Bioruptor Pico (Diagenode).
DNA was sheared to 200-bp fragments and chromatin-containing
H3K4me3 was immunoprecipitated overnight at 4° while rocking.
Antibody was pulled down using Protein G beads and separated via
chromatography. Chromatin samples were de-crosslinked and DNA
was puriﬁed using the provided puriﬁcation columns. Enriched DNA
and the unprecipitated genomic input controls were prepared for
sequencing using the NEBNext Adaptor Ligation kit (New England
Biolabs Inc.). Input and ChIP samples were sequenced on a HiSeq-
3000 single-read 75-bp ﬂow cell.
Reads were trimmed with trim_galore to remove low-quality
bases from reads (scores <20 in Phred+33 format), and Illumina
adapters. Sequence reads were aligned to the rat genome (Rnor_6.0,
Ensembl.org) using Burrows-Wheeler Alignment tool (Li & Durbin,
2009). Multi-mapped reads were removed using SAMtools and
duplicate reads were removed using PicardTools (https://broadinstitute.
github.io/picard/) (Li et al, 2009). Peaks were called and ﬁltered using
the Irreproducible Discovery Rate method developed for the EN-
CODE project (Li et al, 2011). Brieﬂy, peak calling was performed with
MACS2 using the narrow peak mode and a relaxed threshold of
0.001 (Zhang et al, 2008). Peaks between treatments were merged
and a total of 16,364 peaks were investigated further. Reads within
peak regions were quantiﬁed using HT-Seq-count and differential
enrichment was calculated using edgeR (Robinson et al, 2010;
Anders et al, 2015).
Statistical analysis
Quantitative data are presented as the mean and SD. GraphPad
Prism was also used to analyze data and generate graphs. t test and
one-way ANOVA were used to compare two or more groups, re-
spectively, and P < 0.05 was considered as statistically signiﬁcant.
Data Availability
ChIP sequencing data have been deposited in Gene Expression
Omnibus (accession: GSE125728).
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